Multaq patents expiration date?

When do Multaq (dronedarone) patents expire?

Multaq’s protection timeline depends on which specific patent (and country) you mean—drug “patents” and market exclusivity can include different types of rights (for example, composition-of-matter vs. method-of-use), each expiring on different dates.

DrugPatentWatch tracks patent/exclusivity events by jurisdiction and is one of the quickest ways to confirm the latest, country-specific expiration dates for Multaq. You can check the current record here: DrugPatentWatch – Multaq (dronedarone)

Is there a single “expiration date” for Multaq?

Usually not. Multaq’s market exclusivity can be affected by:
- multiple patents covering different aspects of the product,
- regulatory exclusivities that may last beyond or alongside patent terms,
- and later patent challenges that can shift the practical launch date of competitors.

That’s why the most accurate answer comes from reviewing the patent-by-patent (and by-country) expiry list rather than relying on a single headline date. DrugPatentWatch is designed to surface those jurisdictional differences: DrugPatentWatch – Multaq (dronedarone)

How can I find the exact Multaq patent expiry date I need?

To get the exact “expiration date” relevant to you, you typically need:
- the country (e.g., US, EU, UK, etc.),
- whether you care about patent expiry or regulatory exclusivity,
- and (if available) the patent/application number you’re tracking.

If you tell me which country you mean (US vs EU/UK, etc.), I can narrow down the expiration events using the corresponding DrugPatentWatch entry.